Brainstem neurons emerge as a control point for blood pressure stability
A small population of nerve cells in the brainstem appears to act as a stabilizing circuit for blood pressure, helping prevent the rapid swings that can strain the heart, brain, and blood vessels even when average readings appear acceptable. The work from the University of Virginia School of Medicine points to a hidden layer of cardiovascular control that standard office measurements do not capture. In practical terms, the finding pushes blood pressure assessment beyond a single number taken at a single moment.
Rapid changes in blood pressure have long been recognized as harmful, but the biology behind those swings has been less clear. A person can have a mean blood pressure that sits in a normal range and still experience abrupt rises and falls during sleep, waking, standing, and exercise. Those fluctuations can stress the cerebral circulation and the cardiovascular system in ways that average values fail to reveal.
A loss of only a few hundred cells disrupted moment-to-moment control
Investigators identified a small group of neurons in the brainstem that helps keep blood pressure steady across everyday behavioral states. The key message from the study is stark: losing just a few hundred of these cells was enough to produce unstable blood pressure despite a normal mean reading. In other words, the buffering system failed while the headline number stayed deceptively reassuring.
That result carries obvious bedside implications. A clinician relying only on an average clinic measurement could miss a patient whose physiology is drifting into dangerous variability between visits, or even within a single day. The consequence is not merely theoretical. Blood pressure volatility itself has been tied to greater risk of heart disease, stroke, and brain injury.
The brainstem is well suited to this role because it governs involuntary functions that must adapt continuously to changing demands. Standing up, falling asleep, waking suddenly, or beginning physical activity all require rapid recalibration of vascular tone and sympathetic output. When that calibration falters, blood pressure can swing too far in either direction.
A link to multiple system atrophy points to a broader vascular signal
The same nerve cells have previously been found damaged or absent in multiple system atrophy, a rare and fatal neurological disorder related to Parkinson’s disease. Severe blood pressure dysregulation is a familiar feature of that condition, and the new findings strengthen the idea that these neurons are central to that instability. Their absence in a neurodegenerative disorder also gives the work a pathophysiological anchor: when this control circuit is injured, blood pressure control becomes erratic.
What makes the new study clinically interesting is the possibility that the same mechanism may operate outside rare neurodegenerative disease. If disruption of these neurons contributes to blood pressure variability more broadly, then a patient could face cardiovascular risk without meeting the usual threshold for hypertension. That would help explain why some people with seemingly normal averages still develop downstream vascular injury.
Abbott described the finding in direct terms: the loss of a small number of neurons was enough to make blood pressure unstable even though mean pressure remained normal. The implication is hard to ignore. A system designed to smooth short-term fluctuations can fail quietly, and the failure may matter as much as sustained elevation.
Why average blood pressure may not be enough
Routine blood pressure care has traditionally focused on reducing the number itself, especially the systolic and diastolic readings that define hypertension. This study argues for a wider frame: stability matters, not just magnitude. The autonomic circuitry that preserves moment-to-moment balance may be a separate therapeutic target from the mechanisms that simply raise baseline pressure.
That distinction could reshape future treatment strategies. Drugs or interventions aimed at dampening excessive variability might protect the heart and brain even in patients whose average readings do not look alarming. The concept also raises the possibility of refined monitoring approaches that track fluctuations across the day rather than relying solely on office-based checks.
For patients, the finding may eventually change the meaning of a “normal” blood pressure reading. Normal on paper does not always mean normal in physiology. If the brainstem circuit that keeps blood pressure steady is impaired, the vascular system may still be absorbing harmful stress in the background.
Circulation Research publication and research context
The findings were published in Circulation Research by George M.P.R. Souza, Harsha Thakkalapally, Faye E. Berry, Leah F. Wisniewski, Ulrich M. Atongazi, Daniel S. Stornetta, and Stephen B.G. Abbott. The research team reported no financial interests related to the study, and funding came from the National Institutes of Health through grant HL148004.
The work also fits the broader mission of the Paul and Diane Manning Institute of Biotechnology at UVA, which is designed to move difficult laboratory discoveries toward patient-facing treatment. In this case, the translational question is unusually concrete: can the biology of blood pressure variability be targeted before it translates into stroke, cardiac injury, or progressive brain damage?
One sentence captures the clinical tension left by the study. A blood pressure average can look normal while the underlying control system is failing.
What remains unresolved is how often this hidden instability occurs in everyday hypertension care and whether future therapies can restore the missing buffering function without disrupting normal autonomic responses to daily life.